Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network. (Q45777562)
Jump to navigation
Jump to search
scientific article published in December 1993
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network. |
scientific article published in December 1993 |
Statements
Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network (English)
R B Belshe
G J Gorse
J McElrath
M L Clements
R Dolin
D Schwartz
M C Keefer
1 December 1993